GPX2 and neoplasm: To identify the overrepresented upstream regulators that may explain the GPx2 KD-stimulated changes in gene expression, we analyzed the top 583 genes that were significantly differentially expressed in the GPx2 KD relative to the control tumor, using Ingenuity Pathway Analysis (IPA).